Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseSpinal cord injuryContusionC57BL/6 (wild type, Jackson Laboratories)Femalen = 70 adult mice in total: 10 sham, 60 clip-contusion; behavio…ChABC intrathecal via catheter and osmotic mini-pump; iPS-NSC intraparenchymal stereotactic injection; ciclosporin A subcutaneousChABC 3.64 mU/mL in artificial cerebrospinal fluid infused…Chronic phase: ChABC infusion started 7 weeks after injury; iPS-NSC transplante…
Model: C6/7 laminectomy followed by modified aneurysm clip (FEJOTA mouse clip) contusion-compression at a closing force of 6.5 g for 40 seconds; sham animals received laminectomy only
ChABC pretreatment increased iPS-NSC graft survival from 2.44 plus or minus 1.04 per cent to 7.88 plus or minus 1.60 per cent (p = 0.017) and reduced CSPG and GFAP labelling. Only the combined ChABC plus iPS-NSC group showed significant recovery of forelimb grip strength versus control (mean differ…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.